Investors' Dream: Top 10 Stocks to Buy Now

Table of Contents:

1. Introduction to Investing With All I See is W
2. Disclaimer and Research Recommendation
3. Ticker Number One: Bitcoin
4. Ticker Number Two: Inovio Pharmaceuticals
5. Ticker Number Three: Sorrento Therapeutics
6. Ticker Number Four: VBI Vaccines
7. Ticker Number Five: iBio
8. Ticker Number Six: Zomedica
9. Ticker Number Seven: Quantum Computing
10. Ticker Number Eight: Emerald Bioscience
11. Ticker Number Nine: Orgenesis
12. Ticker Number Ten: Regal Pharmaceuticals
13. Conclusion

Introduction to Investing With All I See is W

Welcome to another episode of Investing With All I See is W, where we discuss personal finances, health, and self-development. In this video, I will share with You my top 10 picks for investment opportunities that can add significant value to your portfolio. However, I want to emphasize that the information I provide should be used as guidance only, and it is essential to conduct your own research before making any investment decisions.

Disclaimer and Research Recommendation

Before diving into the specific ticker picks, I want to acknowledge that investing involves risks, and past performance is not necessarily indicative of future results. The opinions expressed in this video are Based on my own analysis and should not be taken as professional financial advice. It is crucial to consult with a qualified financial advisor or do thorough research before making any investment decisions.

Ticker Number One: Bitcoin

Bitcoin has been making waves in the investment world, and it is essential to consider its potential value in your portfolio. With a Current share price of around $27,000, Bitcoin has recently reached new milestones and gained increased trust and respect from investors. This cryptocurrency has the potential to grow significantly in value over the next decade, making it an attractive long-term investment option.

Ticker Number Two: Inovio Pharmaceuticals

Inovio Pharmaceuticals is a biotech company that has shown promising results in its clinical trials, particularly in the development of a COVID-19 vaccine. With no serious adverse events reported and strong manufacturing partnerships, Inovio Pharmaceuticals has the potential to experience substantial growth in the coming year. The stock price could reach $80 to $100 by the third quarter of 2021, making it an exciting investment opportunity.

Ticker Number Three: Sorrento Therapeutics

San Diego-based biotech company Sorrento Therapeutics has recently submitted an Emergency Use Authorization (EUA) to the FDA for its COVID-19 treatment. With the current state of the pandemic, there is a high possibility of EUA acceptance, leading to a surge in stock price. With potential market expansion and a $34 million funding from DARPA, Sorrento Therapeutics could reach $10 to $15 by the end of the first quarter of 2021.

Ticker Number Four: VBI Vaccines

VBI Vaccines has already submitted marketing authorization in Europe and the FDA for its innovative hepatitis B vaccine. With a high demand for this disease, VBI Vaccines is positioned to make a significant impact worldwide. Additionally, the company is also working on a COVID-19 vaccine. It is expected that VBI Vaccines' stock price may reach $5.50 in the early half of 2021, making it a potential investment opportunity.

Ticker Number Five: iBio

Short-term investors may be interested in iBio as the company is expected to release important news regarding its investigational new drug submission to the FDA for its COVID-19 vaccine. Positive outcomes from clinical trials or regulatory approvals could lead to a quick surge in stock price. With a solid team and strategic partnerships, iBio has the potential to reach $3 by the first quarter of 2021.

Ticker Number Six: Zomedica

Zomedica has shown significant growth in a short period, making it an appealing option for swing or midterm investors. The company is set to commercialize its product, True Forma, for dogs and animals with thyroid problems in March 2021. If True Forma gains popularity, the stock price of Zomedica could break the dollar value range and experience substantial gains within three months.

Ticker Number Seven: Quantum Computing

Quantum Computing is a growing field with significant recognition, and Congress plans to inject $10 billion into its development. QUBT, like the Microsoft of the quantum computing sector, has the potential to mature and Show correlation with the growing popularity of Bitcoin. With a price forecast of $30 to $50 by the first quarter of 2021, QUBT presents an exciting opportunity for investors.

Ticker Number Eight: Emerald Bioscience

Emerald Bioscience is a biotech company focused on advancing healthcare for patients with glaucoma. With innovative products to reduce intraocular pressure, Emerald Bioscience aims to make a difference in this field. From a share price perspective, a forecast of reaching 20 cents in the first quarter of 2021 and up to $1 by the end of the year is possible, making Emerald Bioscience an attractive investment option.

Ticker Number Nine: Orgenesis

Orgenesis is a biotech company that has garnered Attention and investment from Ark Invest. With the demand for biotech soaring, Orgenesis has the potential to experience significant growth in 2021. The forecast for Orgenesis' stock price is reaching $25 to $30 by the first quarter of 2021, making it a Hidden gem worth considering for investment.

Ticker Number Ten: Regal Pharmaceuticals

Regal Pharmaceuticals is a tech company working on a drug to treat hospitalized patients with pneumonia caused by COVID-19. With potential FDA approval, the stock price of Regal Pharmaceuticals could reach beyond its prior resistance value of $4.50. This presents an opportunity for investors looking for low-risk options with potentially high returns.

Conclusion

In conclusion, these 10 tickers have the potential to add significant value to your investment portfolio. However, it is essential to remember that investing comes with risks, and thorough research is necessary before making any investment decisions. Consider consulting with a qualified financial advisor to determine the best investment strategy for your individual needs. As always, stay informed, stay curious, and happy investing!

Highlights

• Bitcoin: Potential to reach $100k within 10 years.
• Inovio Pharmaceuticals: Promising COVID-19 vaccine and potential stock price of $80 to $100 by Q3 2021.
• Sorrento Therapeutics: Expecting EUA acceptance and potential stock price of $10 to $15 by Q1 2021.
• VBI Vaccines: Innovative vaccines for hepatitis B and COVID-19, potential stock price of $5.50 in early 2021.
• iBio: Short-term investment opportunity with upcoming news regarding COVID-19 vaccine and potential stock price of $3 by Q1 2021.
• Zomedica: Growth potential with the commercialization of True Forma and potential stock price surge.
• Quantum Computing: Possible correlation with the growing popularity of Bitcoin, potential stock price of $30 to $50 by Q1 2021.
• Emerald Bioscience: Innovation in glaucoma treatment, potential stock price of 20 cents by Q1 2021 and $1 by year-end.
• Orgenesis: Biotech company with potential for significant growth, potential stock price of $25 to $30 by Q1 2021.
• Regal Pharmaceuticals: Low-risk investment with potential FDA approval and stock price surge beyond $4.50 range.

FAQ

Q: Are these investment recommendations guaranteed to bring positive returns? A: No investment is guaranteed, and it is essential to conduct your own research and consult with a financial advisor before making any investment decisions.

Q: How long should I hold onto these investments for maximum growth? A: The holding period depends on your investment goals and risk tolerance. Some investments may be suitable for long-term strategies, while others may be more appealing for short-term gains.

Q: What are the risks associated with investing in biotech companies? A: Biotech companies can be volatile and subject to regulatory approvals, clinical trial outcomes, and market conditions. It is important to consider the potential risks and rewards before investing in this sector.

Q: Can these investments be part of a diversified portfolio? A: Yes, these investments can be considered as part of a diversified portfolio. However, it is crucial to analyze your overall investment strategy and ensure a balanced approach across different sectors and asset classes.

Q: Where can I find more information about these investment opportunities? A: You can find more information about these investments by conducting thorough research, consulting financial advisors, and staying updated on relevant news and market trends.